Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
Nov 22 LDOS Leidos: Not Enough Margin Of Safety Despite Creating Value In A Low Growth Sector
Nov 22 LDOS 3 High ROE Stocks to Bet on as Markets Surge on Economic Strength
Nov 22 LDOS Zacks Industry Outlook Highlights Leidos, Archer Aviation and Intuitive Machines
Nov 21 LDOS 3 Aerospace-Defense Stocks to Buy Amid Persistent Supply-Chain Issues
Nov 21 LDOS 5 Best Value Stocks With Discounted PEG to Boost Your Portfolio Return
Nov 20 GH Guardant Health Stock Sees RS Rating Jump To 83
Nov 20 GH Guardant Health: Focused On Future Growth, Hold
Nov 20 DCTH Delcath Begins Platform Expansion With Two Phase 2 Trials
Nov 20 LDOS Resource Wars: China and America Battle for Antimony as Prices Surge 200%
Nov 19 IFRX Is InflaRx N.V. (IFRX) the Best German Stock to Buy Now?
Nov 19 LDOS Is Leidos (LDOS) Stock Undervalued Right Now?
Nov 19 MNOV MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders
Nov 19 LDOS Leidos Signs Agreement to Enhance AI Innovation in UK: Time to Buy the Stock?
Nov 18 AUPH Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis
Nov 18 DCTH Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth
Nov 18 LDOS Spotting Winners: Axon (NASDAQ:AXON) And Aerospace and Defense Stocks In Q3
Nov 17 LDOS Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
Nov 17 LDOS The total return for Leidos Holdings (NYSE:LDOS) investors has risen faster than earnings growth over the last five years
Nov 16 LDOS What Moved Markets This Week
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags